Canara Robeco Mutual Fund has picked up 9 lakh equity shares in the pharma firm through open market transactions at an average price of Rs 474.41 each, and Invesco Mutual Fund bought 6 lakh shares at an average of Rs 452.1 on the listing day. In total, they bought a 2.6 percent stake in Innova.

 The step-down subsidiary Dr Reddy’s Laboratories, Inc has acquired 10,14,442 preferred A-1 shares of Edity Therapeutics, an Israel-based development stage biotechnology company, equivalent to 6.46 percent of the shareholding of Edity on a fully diluted basis. These shares were bought for $2 million. Meanwhile, Sanjiv Mehta has been appointed as an additional director on the board of the company for five consecutive years, effective December 29, 2023. Mehta was the CEO and Executive Chairman of Unilever Businesses in different parts of the world for 21 years from 2002–23.

The company has transferred the development rights and associated physical assets of the proposed 1,200 MW KalaiII hydro-electric project at Lohit River Basin of Arunachal Pradesh to THDC for Rs 128.39 crore. The agreement has been signed with the Governor of Arunachal Pradesh, Kalai Power (a subsidiary of the company), and THDC India.

: V. Chakrapani, the current Head of Internal Audit of the bank, superannuated on December 31, 2023. The bank has appointed Suketu Kapadia as the Head of Internal Audit in place of V. Chakrapani. Kapadia is expected to join the bank on or before April 1, 2024.